'Awful to Watch': Perth Mum's Warning About Her Son's Experience with RSV
10 Articles
10 Articles
WHO Approves New Vaccine To Protect Infants From RSV
The World Health Organisation (WHO) has published its first-ever position paper on immunisation products to protect infants against Respiratory Syncytial Virus (RSV), a leading cause of acute lower respiratory infections in children globally. WHO said RSV causes approximately 100,000 deaths and over 3.6 million hospitalisations in children under 5 years worldwide each year. It added that about half of the deaths occur in infants younger than 6 m…
WHO approves new vaccines to protect infants from RSV
The World Health Organisation (WHO), on Friday, issued recommendations for two new immunisation tools to protect infants from Respiratory Syncytial Virus (RSV). They included a maternal vaccine, administered to pregnant women in their third trimester to protect their newborns. The other was a long-acting antibody injection for infants, which begins to protect within a week […] The post WHO approves new vaccines to protect infants from RSV appear…
WHO approves 2 new vaccines to protect infants from RSV
The World Health Organization (WHO) has issued recommendations for two new immunisation tools to protect infants from Respiratory Syncytial Virus (RSV) They included a maternal vaccine, administered to pregnant women in their third trimester to protect their newborns. The other was a long-acting antibody injection for infants, which begins to protect within a week of administration and lasts for at least five months. According to WHO, RSV is the…
Interference between respiratory viruses in a cohort of healthy young children; a self-controlled case-series study
Authors: Hauser van Westrhenen E, Junquera Guinovart L, Schuurman R, van Boven M, Bonten M, Bruijning Verhagen P. Presented at: ESPID 2025 View presentation The post Interference between respiratory viruses in a cohort of healthy young children; a self-controlled case-series study first appeared on Penta.
WHO calls for maternal vaccine, monoclonal antibody to protect babies against RSV
New Delhi: The World Health Organization (WHO) on Friday recommended all countries to use both maternal vaccine and a monoclonal antibody to protect babies against respiratory syncytial virus (RSV) -– the leading cause of acute lower respiratory infections in children globally. While the maternal vaccine -- RSVpreF -- can be given to pregnant women in their third trimester to protect their infant, the long-acting monoclonal antibody -- nirsevim…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage